[OSEN=Park Geun-hee Reporter] Amid Lim La-la and Son Minsoo enjoying their free time after childbirth, the bittersweet truth about the whereabouts of their daughter Danni’s double eyelid has been ...
The Centre has intensified its crackdown on the misuse and unauthorised sale of popular weight-loss and diabetes drugs, amid growing concerns over their easy availability across online platforms, ...
For decades, we have given primacy to a single metric—our weight. This has been the prime measure of health, at least at the household level. In 2026, and we’re long past that, as there are a lot more ...
Modern India has a bulging waistline. Over 100 million Indians are affected by obesity. Worryingly, projections reveal that one out of every three Indians would be overweight by 2050. Ironically, the ...
NEW DELHI: The booming demand for weight-loss drugs has now caught the attention of India’s drug regulator, with a series of raids across the country revealing just how easily these prescription ...
The noose is set to tighten around the main accused, Ajay Pratap Singh, and his associates in the sensational murder of two officials at the HPCL plant in Badaun’s Sainjani village, with authorities ...
A day after a 45-year-old woman and her visually impaired son were found murdered at their home in Sisendi under Mohanlalganj police station limits, investigators are probing people who had gathered ...
Wegovy maker Novo Nordisk said it is teaming up with Hims & Hers Health to sell its weight-loss drugs through the telehealth company’s platform, bringing an end to a legal dispute between the two ...
BERLIN, March 3 (Reuters) - Swiss pharmaceutical company Roche (ROG.S), opens new tab is aiming for a double-digit market share in the weight loss market and wants to close the gap on its Danish ...
Add Yahoo as a preferred source to see more of our stories on Google. The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann BERLIN ...
Eli Lilly has spent months signaling it would challenge Novo Nordisk’s oral GLP-1 franchise. Now it has data to back that up. According to lead investigator Dr. Julio Rosenstock, Lilly’s pill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results